. 1980:7:883-5.

Plasma indomethacin levels in preterm newborns with symptomatic patent ductus arteriosus: clinical and echocardiographic assessments of response

B S Alpert et al. Adv Prostaglandin Thromboxane Res. 1980.

. 1980:7:883-5.

No abstract available

Similar articles

Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus--clinical and echocardiographic assessments of response.
Alpert BS, Lewins MJ, Rowland DW, Grant MJ, Olley PM, Soldin SJ, Swyer PR, Coceani F, Rowe RD. Alpert BS, et al. J Pediatr. 1979 Oct;95(4):578-82. doi: 10.1016/s0022-3476(79)80774-x. J Pediatr. 1979. PMID: 480038 No abstract available.
[Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
Marchal F, Monin P, Vert P, Bianchetti G, Morselli PL. Marchal F, et al. Arch Fr Pediatr. 1981 Aug-Sep;38(7):503-8. Arch Fr Pediatr. 1981. PMID: 7283656 French.
Late closure of the ductus arteriosus using indomethacin in the preterm infant.
Kresch MJ, Moya FR, Ascuitto RJ, Ross-Ascuitto NT, Heusser F. Kresch MJ, et al. Clin Pediatr (Phila). 1988 Mar;27(3):140-3. doi: 10.1177/000992288802700305. Clin Pediatr (Phila). 1988. PMID: 3342597
Patent ductus arteriosus in the preterm infant.
Kirsten D. Kirsten D. Neonatal Netw. 1996 Mar;15(2):19-26. Neonatal Netw. 1996. PMID: 8700090 Review.
Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
Hammerman C. Hammerman C. Clin Perinatol. 1995 Jun;22(2):457-79. Clin Perinatol. 1995. PMID: 7671547 Review.